back in Medical Technology

Relievant Medsystems Announces Completion of $20 Million Financing

... minimally invasive treatment for chronic low back pain, reported today that it has completed a $20 ... launch of our Intracept(TM) System to treat low back pain," commented Paul Goeld, President and Chief ... of our technology." Chronic low back pain impacts nearly one-third of the population ...

SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... of the hands, wrists, knees, ankles, feet, lower back and neck are commonly affected. Psoriasis ... of spinal arthritis, and symptoms of inflammatory back pain often first present in people under the age ... and other joints. Often misdiagnosed as "just back pain" or undifferentiated arthritis, AS is a ...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

... percent improvement from baseline in both total back pain and morning stiffness measures were switched ... of the hands, wrists, knees, ankles, feet, lower back and neck are commonly affected. Psoriasis ... of spinal arthritis, and symptoms of inflammatory back pain often first present in people under the age ...

Three Surgeons in East Texas Are Successfully Integrating a Novel Stem Cell Procedure for Spine Surgeries

... the desired results of surgical interventions for back pain. Leading researchers in the orthopedic and ... of care for surgical treatments of severe back pain. Dr. Lee Buono, Dr. Freddie Contreras, ... device and the living cells are delivered back to the surgeon in a concentrated dose to be ...

Back to Normal: Surgery Improves Outcomes for Spine Patients

... the study, SPORT looked at the three most common back conditions leading to surgery, which are: ... Approximately 80 percent of Americans suffer from back pain at some point in their lives. back pain is the most common cause of work-related ...

Three Clinical Presentations on Tapentadol Extended Release Tablets for Chronic Pain Featured at 2009 American Pain Society Annual Meeting

... challenge in the United States, and chronic low back pain is the most common cause of disability in ... tablets to treat patients with chronic low back pain, including pivotal Phase 3 safety, efficacy ... and Safety of Tapentadol ER for Chronic Low back Pain: Results of a Randomized, Double-blind, ...

Oh, My Aching Back: Give Me a Shot of Ozone

... the pain associated with herniated disks. back pain is the most common cause of job-related ... bones (vertebrae) that form the spine in the back are cushioned by small, spongy disks. When these ... or break open. "There are millions of people with back pain who suffer and who can't work because of ...

Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange

... that can assist in the diagnosis and treatment of back and neck injuries and illness. The trial is ... and indirect cost of diagnosing and treating back injuries is estimated to be between $50-$100 ... make MPR widely available to those suffering from back pain. With the data we obtain from this study, ...

Aching Back? Cholesterol Medication Might Help

... LAS VEGAS, Feb. 22 /PRNewswire-USNewswire/ -- back pain, a hallmark of degenerative disc disease, ... a living organism). They then transfer the cells back into the patient. Shu-Hua Yang, MD, PhD, is part ... cell transplantation (reimplanting cells back into the same individual the cells came from). ...

Study Shows No Standardized Approach to Epidural Steroid Injections for Back Pain

... administering an epidural steroid injection for back pain. Researchers looked at many ... procedures used to treat pain in the neck, arms, back and legs caused by inflamed nerves. While ... important and common option for the treatment of back pain. However, we found that a great variety of ...

ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease

... of microplasmin for the non-surgical treatment of back of the eye disease, the final step in the ... step in potentially improving the treatment of back of the eye disease, and is a major milestone in ... is thought to play a key role in numerous back of the eye conditions such as macular hole ...

MRI Emerges As Vital Resource in Treatment of Back Pain

... clinical benefits when used in the evaluation of back pain according to an article in the January 2009 ... clinical needs." Those include: back pain Infection Tumor ... information needed for diagnosis in many back pain cases. However, CT does include some ...

Texas Back Institute Leads Way in New Facet Joint Clinical Trial

... PLANO, Texas, Nov. 6 /PRNewswire/ -- Texas back Institute is leading the way again in motion ... (TFAS)(R). Dr. Barton Sachs of Texas back Institute performed the TFAS procedure on Ron ... 40 people worldwide to receive TFAS. He is now back on the golf course and enjoying his life to the ...

APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism

... hour or so to work the leg muscles and ease the back -- that is, if the captain has turned off the ... fluid build-up in the legs, and stretching the back and the muscles around the torso will prevent ... Moffat. Moffat notes that if you have an existing back problem, appropriate guidance should be given to ...

Say 'Goodbye' to Back Fat Rolls

... ASPS Study Introduces New Bra-Line back Lift ARLINGTON HEIGHTS, Ill., Sept. 12 ... by our rear reflection and the sight of dreaded back fat rolls and lumps. A study published in the ... of Plastic Surgeons (ASPS), reveals a new back lift procedure that removes these unsightly bumps ...

Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist

... one of the nation's leading pain specialists. back pain is the most disabling pain experienced by ... and treating muscle-related pain have brought back pain relief to thousands of long-suffering ... in over 75 percent of his chronic back pain patients. Dr. Marcus credits his ...

Researchers Train the Immune System to Deliver Virus That Destroys Cancer in Lab Models

... them with the virus and injected the T-cells back into the mouse. Researchers found that once the ... patients, attach the virus and inject the cells back into the patients. Doctors currently use a ... this virus and then putting those T-cells back into patients whose cancer has spread to lymph ...

Interview of the Vice President

... I thought Jack got it right when he came back and said the surge is working. I think it is. And ... with in Iran. The reality is that if you go back to a few years ago, Iran had two programs. They ... through the surge, in a sense, and will be going back to pre-surge levels over the course of the next ...

R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023

... skin for 48 hours (2) Closed patch test: Closed patch dressing to the back skin for 48 hours (3) Photo-patch test: Closed patch dressing to the back skin for 24 hours, followed by UVA irradiation No ...

ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule

... Moreover, vitreomacular adhesion is thought to play a key role in numerous back of the eye conditions such as macular hole formation, and some forms of ... could potentially make a significant difference to the treatment of back of the eye disease and we very much look forward to reporting the results ...

Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion

... is caused by obstruction of the central retinal vein that that leads to a back up of blood and fluid in the retina, resulting in retinal injury and loss ... CRVO is caused by obstruction of the central retinal vein that leads to a back up of blood and fluid in the retina, resulting in retinal injury and loss ...

DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program

... patches and oral opioids. Effective August 26, 2009, we will receive back from Endo Pharmaceuticals the right to develop and commercialize ... committed to assist us in an orderly and rapid transition of this program back to us. With the worldwide rights to this program restored to us, we ...

Advances in Science and Treatment of Pain Presented at 25th Annual American Academy of Pain Medicine Meeting January 28 - 31, 2009

... MD MPH. "We have also seen an exponential increase in interventions for back pain, migraines, and traumatic injury patients. And there has been ... Ballroom, Hilton Hawaiian Village WAR and PAIN: From Battlefield to back Home Chester 'Trip' Buckenmaier, III, MD COL MC and R. Norman Harden, ...

Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma

... (each 17%), pain in limb and abdominal pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ... insomnia (20% vs 13%), edema peripheral (20% vs 10%), rash (19% vs 7%), back pain (17% vs 18%), pneumonia (16% vs 11%), dizziness (16% vs 11%), dyspnea ...

Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients

... (each 17%), pain in limb and abdominal pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ... insomnia (20% vs 13%), edema peripheral (20% vs 10%), rash (19% vs 7%), back pain (17% vs 18%), pneumonia (16% vs 11%), dizziness (16% vs 11%), dyspnea ...

Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients

... (each 17%), pain in limb and abdominal pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ... insomnia (20% vs 13%), edema peripheral (20% vs 10%), rash (19% vs 7%), back pain (17% vs 18%), pneumonia (16% vs 11%), dizziness (16% vs 11%), dyspnea ...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

... are generally mild to moderate and may include bone pain, hot flashes, back pain, nausea, joint pain, shortness of breath, tiredness, coughing, ... (excluding vertigo) (18%), insomnia (16%), decreased weight (16%), back pain (15%) and paresthesia (15%). Caution is advised when ...

Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain

... that is supportive but didn't meet its primary endpoint -- in chronic low back pain. In discussions between Lilly and the FDA, agency reviewers raised ... al. Duloxetine versus Placebo in the Treatment of Chronic Low back Pain. Poster presented at the 12th World Congress of Pain. 21 ...

Multi-Centre European Clinical Trial Shows Advanced Dysplasia and Early Cancer of Esophagus Cured With Combined Endoscopic Resection and Radiofrequency Ablation With HALO Ablation System

... the Netherlands, was the senior investigator for this study. "In several back to back studies now, we have been successful in using the HALO Ablation System ...

New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients

... insomnia (20% vs 13%), edema peripheral (20% vs 10%), rash (19% vs 7%), back pain (17% vs 18%), pneumonia (16% vs 11%), dizziness (16% vs 11%), dyspnea ... (each 17%), pain in limb and abdominal pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper ...

Braking After Bunion Surgery

... surgery, most patients' pain levels are so low that they are able to get back behind the wheel of a car again. A study published in the August 2008 ... required to realign the bone, ligaments, and tendons and bring the big toe back to its correct position. After this surgery, many patients main concern is ...

Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology

... and began offering image-guided IMRT treatments for prostate cancer back in August 2005. "The vast majority of our patients since then have had no ... tasks will help us ensure that charges are captured correctly, and cut back on time-consuming billing errors." Shorkey is now finishing his third ...

New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder

... also learned that the rate at which deoxycholic acid (DCA) was recycled back into the liver (i.e. DCA input rate) was almost twice as great in those ... and a global leader in pharmaceutical innovation whose roots date back to 1899. The company is dedicated to the discovery, development and ...

New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR

... this study and its presentation. In this study, patients with low back pain or pain from osteoarthritis of the knee or hip were treated with a ... parallel group, multi-center trial of 878 patients with low back pain or pain from osteoarthritis of the knee or hip studied the ...

Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)

... patients who awake in the middle of the night and have difficulty falling back asleep. "This is the fifth product candidate using our single-dose ... falling asleep (21%), and waking up too early and not being able to get back to sleep (21%). There is a potentially significant clinical need for rapid ...

ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)

... A vitrectomy is a surgical procedure carried out in the treatment of many back of the eye diseases such as retinal detachment, diabectic vitreous ... Microplasmin has the potential to significantly change the way we treat back of the eye diseases and this study will bring us a step closer to ...

VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy

... five years of tamoxifen reduced their risk of breast cancer coming back by 63% compared to those who did not start Femara(1). In addition, the ... data reinforce the need for women diagnosed with breast cancer to go back to their doctors and continue to discuss ways to reduce their risk of ...

Seven-Year Neck Pain Study Sheds Light on Best Care

... Los Angeles. "It can be associated with headaches, arm and upper back pain and depression. Whether it arises from sports injuries, car ... of benefits. -- Once you have experienced neck pain, it may come back or remain persistent. -- Lengthy treatment is not associated with ...

Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status

... patients who awake in the middle of the night and have difficulty falling back asleep. This is the first clinical trial of AZ-007 being conducted under ... falling asleep (21%), and waking up too early and not being able to get back to sleep (21%). There is a potentially significant clinical need for rapid ...

YouthAIDS, Levi's and BET's Rap It-Up Campaign Kick Off 2007 'Kick Me' Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country

... Nov. 20 /PRNewswire-USNewswire/ -- Look out for the Kick Me sign. It's back on the backs of college students around the nation. YouthAIDS, an ... is based on the old prank of someone sticking a Kick Me sign on another's back without their knowledge -- just like 90% of those infected HIV/AIDS may ...